Bespoke Extracts (BSPK) EBIT Growth (5y) (2016 - 2021)
Bespoke Extracts (BSPK) EBIT Growth (5y) (2016 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Bespoke Extracts | - | - | 234,175.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2021 | -10.27% |
| Aug 31, 2021 | 123.25% |
| May 31, 2021 | -34.05% |
| Feb 28, 2021 | -11.05% |
| Nov 30, 2020 | -20.04% |
| May 31, 2020 | -120.29% |
| Feb 29, 2020 | -26.85% |
| Nov 30, 2019 | -49.88% |
| Aug 31, 2019 | -32.26% |
| May 31, 2019 | -30.44% |
| Feb 28, 2019 | -20.05% |
| Nov 30, 2018 | 117.50% |
| Aug 31, 2018 | -96.12% |
| May 31, 2018 | -104.93% |
| Feb 28, 2018 | -81.73% |
| Nov 30, 2017 | -60.21% |
| May 31, 2017 | -145.44% |
| Feb 28, 2017 | 17.43% |
| Nov 30, 2016 | 6.41% |